BIIB

Biogen
BIIB

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$19.14B
EV
$23.17B
Shares Outstanding
146.53M
Beta
0.15

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$171.95
P/E 2025E
8.81x
P/Revenue 2025E
2.07x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biogen Inc.

gainify
BIIB

Biogen Inc.

BIIB

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FA...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Viehbacher, Christopher

Employees

7,605

IPO Date

1991-09-17

Headquarters

225 Binney Street, Cambridge, Massachusetts, 02142, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.